During the past decade, Osceola Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osceola Cancer Center" #1 sponsor was "CTI BioPharma" with 1 trials, followed by "East Valley Hematology and Oncology Medical Group" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osceola Cancer Center" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Osceola Cancer Center" are "Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large-Cell Lymphoma" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Osceola Cancer Center" in a lesser frequency.

Most popular intervention types in "Osceola Cancer Center" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "zoledronic acid" (2 trials), "CHOP-R" (1 trials), "CPOP-R" (1 trials), "Carboplatin" (1 trials) and "Mapatumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osceola Cancer Center" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Osceola Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Osceola Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osceola Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".